Global acne market to exceed $7bn by 2025

By Sarah Parsons 31-May-2017

The backfire of self-medication is said to be the key driving force for the acne industry's growth

The global acne market will be worth over $7bn mark by 2025, latest research suggests.

Market research company Persistence Market Research (PMR) have said the market is set to rise from $4.9bn in 2016 to $7.3bn by 2025, reflecting an annual growth rate of 4.6%.

It says that the inflammatory acne segment is the main reasons for the category’s growth. The firm estimates that while the sub-category will maintain 60% of its market share, it will grow from $3bn to $4.5bn by 2025.

The market research company claims that teenage consumers are turning to acne treatment drugs and medication, after becoming disenchanted with the self-medication alternatives.

According to PMR, 20% of under 13-year-olds suffer from moderate-to-severe acne issues.

“The average age of onset of acne has reduced from 14-15 years to 11-12 years due to changing demographics and social habits,” the report said.

“Moreover, some of the misleading media content continue to encourage the habit of self-medication that often backfires, resulting in further complications.”

The US and Asia-Pacific are expected to remain key markets for the acne market. The US is expected to exceed $3.2bn by 2025 and to account for 43% of the global market share.

Sign up for your free email newsletter

Asia-Pacific will reach $1.7bn by 2025 and is expected to expand to 4.8% of the revenue share.

Companies

Subscriber Help

Related Content

The trends taking the beauty world by storm in 2017 and beyond
The trends taking the beauty world by storm in 2017 and beyond